Accurate prediction of progression to muscle-invasive disease in patients with pT1G3 bladder cancer: A clinical decision-making tool

To improve current prognostic models for the selection of patients with T1G3 urothelial bladder cancer who are more likely to fail intravesical therapy and progress to muscle-invasive bladder cancer (MIBC).

Source: Urologic Oncology: Seminars and Original Investigations - March 2, 2018 Category: Urology & Nephrology Authors: David D ′Andrea, Mohammad Abufaraj, Martin Susani, Robin Ristl, Beat Foerster, Shoji Kimura, Andrea Mari, Francesco Soria, Alberto Briganti, Pierre I. Karakiewicz, Killian M. Gust, Morgan Rouprêt, Shahrokh F. Shariat Tags: Original article Source Type: research